STOCK TITAN
  1. Home
  2. Sec-filings
  3. VLRS
  4. [Form 4] Controladora Vuela Compania de Aviacion, S.A.B. de C.V. Insider Trading Activity

Director at Controladora Vuela (NYSE: VLRS) exercises RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Controladora Vuela Compania de Aviacion director Guadalupe Phillips Margain increased her direct equity stake through routine equity compensation activity. On April 28, 2026, she exercised previously granted restricted securities units into 204,866 Series A common shares at a stated price of $0.00 per share, bringing her direct holdings to 363,379 shares.

The derivative entries show two RSU lines converting into 106,461 and 98,405 Series A shares, matching the 204,866-share acquisition. Footnotes explain that earlier RSUs were granted on April 28, 2025 and vested on April 28, 2026, each unit representing one Series A share. Separate entries on April 24, 2026 record new RSU awards of 56,811 BoDIP units and 52,531 Annual Fee units, which will vest on April 24, 2027 and have no expiration date.

Positive

  • None.

Negative

  • None.
Insider PHILLIPS MARGAIN Guadalupe
Role null
Type Security Shares Price Value
Exercise Restricted Securities Units (Annual Fee) 98,405 $0.00 --
Exercise Restricted Securities Units (BoDIP) 106,461 $0.00 --
Exercise Series A shares of common stock 204,866 $0.00 --
Grant/Award Restricted Securities Units (Annual Fee) 52,531 $0.00 --
Grant/Award Restricted Securities Units (BoDIP) 56,811 $0.00 --
Holdings After Transaction: Restricted Securities Units (Annual Fee) — 0 shares (Direct, null); Restricted Securities Units (BoDIP) — 0 shares (Direct, null); Series A shares of common stock — 363,379 shares (Direct, null)
Footnotes (1)
  1. The Restricted Securities Units ("RSUs") were granted on April 28, 2025 and vest on April 28, 2026. The RSUs have no expiration date. Each RSU represents a contingent right to receive on Series A share of common stock. The RSUs were granted on April 24, 2026 and will vest on April 24, 2027. The RSUs have no expiration date.
Shares acquired via RSU exercise 204,866 shares Series A common stock acquired on April 28, 2026
Shareholdings after transaction 363,379 shares Direct Series A holdings following April 28, 2026 exercise
BoDIP RSUs exercised 106,461 units Restricted Securities Units (BoDIP) converting into Series A shares
Annual Fee RSUs exercised 98,405 units Restricted Securities Units (Annual Fee) converting into Series A shares
New BoDIP RSU grant 56,811 units Granted April 24, 2026, vesting April 24, 2027
New Annual Fee RSU grant 52,531 units Granted April 24, 2026, vesting April 24, 2027
Restricted Securities Units financial
"The Restricted Securities Units ("RSUs") were granted on April 28, 2025 and vest on April 28, 2026."
RSUs financial
"Each RSU represents a contingent right to receive on Series A share of common stock."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Series A shares of common stock financial
"security_title: "Series A shares of common stock""
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PHILLIPS MARGAIN Guadalupe
(Last)(First)(Middle)
AV. ANTONIO DOVALI JAIME 70, TOWER B, 13
FLOOR, COLONIA ZEDEC SANTA FE
(Street)
MEXICO CITY01210
(City)(State)(Zip)
MEXICO
(Country)		2. Issuer Name and Ticker or Trading Symbol
Controladora Vuela Compania de Aviacion, S.A.B. de C.V. [ VLRS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
[VOLAR]
3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Series A shares of common stock04/28/2026M(1)204,866A(2)363,379D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Securities Units (Annual Fee)(2)04/24/2026A52,531 (3) (3)Series A shares of common stock52,531$052,531D
Restricted Securities Units (BoDIP)(2)04/24/2026A56,811 (3) (3)Series A shares of common stock56,811$056,811D
Restricted Securities Units (Annual Fee)(2)04/28/2026M98,405 (1) (1)Series A shares of common stock98,405$00D
Restricted Securities Units (BoDIP)(2)04/28/2026M106,461 (1) (1)Series A shares of common stock106,461$00D
Explanation of Responses:
1. The Restricted Securities Units ("RSUs") were granted on April 28, 2025 and vest on April 28, 2026. The RSUs have no expiration date.
2. Each RSU represents a contingent right to receive on Series A share of common stock.
3. The RSUs were granted on April 24, 2026 and will vest on April 24, 2027. The RSUs have no expiration date.
/s/ Isela Cervantes Rodriguez, as Attorney-in-Fact, for Guadalupe Phillips Margain04/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did VLRS director Guadalupe Phillips Margain report?

Guadalupe Phillips Margain reported routine equity compensation transactions. She exercised restricted securities units into 204,866 Series A common shares and received new RSU grants tied to board service and annual fees, all at a stated price of $0.00 per unit or share.

How many VLRS shares does Guadalupe Phillips Margain hold after these transactions?

After these transactions, she directly holds 363,379 Series A common shares. This total reflects the exercise of 204,866 shares from previously granted RSUs, as reported in the non-derivative transaction table within the Form 4 filing.

What RSU grants did VLRS director Guadalupe Phillips Margain receive in April 2026?

On April 24, 2026, she received two new RSU awards. These comprised 56,811 restricted securities units under a BoDIP program and 52,531 RSUs as an Annual Fee award, each unit representing a contingent right to one Series A share of common stock.

When do Guadalupe Phillips Margain’s new VLRS RSU grants vest?

The April 24, 2026 RSU grants vest on April 24, 2027. Footnotes specify that these RSUs have no expiration date and each unit converts into one Series A common share upon vesting, subject to the program’s standard conditions.

What was the origin of the RSUs that Guadalupe Phillips Margain exercised into VLRS shares?

The exercised RSUs were granted on April 28, 2025. Footnotes state these units vested on April 28, 2026 and carried no expiration date, with each restricted securities unit representing a contingent right to receive one Series A share of common stock.

Were Guadalupe Phillips Margain’s VLRS transactions open-market buys or compensation-related events?

The transactions were compensation-related, not open-market purchases. All entries use codes M and A, reflecting derivative exercises and grants of restricted securities units at a stated price of $0.00, consistent with equity awards rather than market trading activity.